Vedanta Biosciences’ dreams of using live bacteria to treat inflammatory bowel disease (IBD) have been dashed. The Massachusetts-based microbiome outfit’s mixture of 16 bacterial strains failed to ...
Vedanta Biosciences has “significantly reduced” its headcount to channel its remaining resources to its lead live bacteria cocktail program. The company is now “laser-focused” on a phase 3 study of ...
This post is part one of a three-part series. Vedanta teacher Gautam Jain (addressed as Gautamji) is a senior protégé of renowned philosopher and author A. Parthasarathy. Currently the head of the ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vedanta Biosciences, a clinical-stage company that is developing a potential new category of oral therapies based on defined bacterial consortia, today announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results